Pancreatic Cancer Research

ResearcherJikei University School of MedicineNo recent work listed

Masato Okamoto

Verified by OpenAlex author ID (good confidence, 0.85), identity_conf@1As of 7 November 2026

Matched on OpenAlex author ID A5113541299. Sources: OpenAlex.

Their work

Papers
15 (first author 2, last author 0)
Trials
0
Grants
0
Labs led
0
Collaborators
34
Papers, trials and grants by year

2014: 3 papers · 2015: 3 papers · 2016: 3 papers · 2017: 1 paper · 2018: 2 papers · 2019: 3 papers

Papers 15

  1. Clinical Significance of Tumor-Infiltrating T Cells and Programed Death Ligand-1 in Patients with Pancreatic Cancer. Co-author DOI 10.1080/07357907.2019.1661427↗
  2. Long-term survival of pancreatic cancer patients treated with multimodal therapy combined with WT1-targeted dendritic cell vaccines. Co-author DOI 10.1080/21645515.2018.1524238↗
  3. Predicted Markers of Overall Survival in Pancreatic Cancer Patients Receiving Dendritic Cell Vaccinations Targeting WT1. Co-author DOI 10.1159/000500359↗
  4. WT1-pulsed Dendritic Cell Vaccine Combined with Chemotherapy for Resected Pancreatic Cancer in a Phase I Study. Co-author DOI 10.21873/anticanres.12464↗
  5. Prognostic significance of Wilms' tumor 1 expression in patients with pancreatic ductal adenocarcinoma. Co-author DOI 10.3892/ol.2018.8961↗
  6. Significance of Wilms' tumor 1 antigen as a cancer vaccine for pancreatic cancer. First author PMID 28950074↗
  7. Wilms' tumor 1 (WT1)-targeted cancer vaccines to extend survival for patients with pancreatic cancer. First author DOI 10.2217/imt-2016-0031↗
  8. Comprehensive assessment of the prognosis of pancreatic cancer: peripheral blood neutrophil-lymphocyte ratio and immunohistochemical analyses of the tumour sit… Co-author DOI 10.3109/00365521.2015.1121515↗
  9. Dendritic cell-based vaccine for pancreatic cancer in Japan. Co-author DOI 10.4292/wjgpt.v7.i1.133↗
  10. Phase I pilot study of Wilms tumor gene 1 peptide-pulsed dendritic cell vaccination combined with gemcitabine in pancreatic cancer. Co-author DOI 10.1111/cas.12621↗
  11. Up-regulation of HER2 by gemcitabine enhances the antitumor effect of combined gemcitabine and trastuzumab emtansine treatment on pancreatic ductal adenocarcin… Co-author DOI 10.1186/s12885-015-1772-1↗
  12. Prognostic markers for patient outcome following vaccination with multiple MHC Class I/II-restricted WT1 peptide-pulsed dendritic cells plus chemotherapy for p… Co-author PMID 25550602↗
  13. Prognostic factors related to add-on dendritic cell vaccines on patients with inoperable pancreatic cancer receiving chemotherapy: a multicenter analysis. Co-author DOI 10.1007/s00262-014-1554-7↗
  14. Treatment with chemotherapy and dendritic cells pulsed with multiple Wilms' tumor 1 (WT1)-specific MHC class I/II-restricted epitopes for pancreatic cancer. Co-author DOI 10.1158/1078-0432.ccr-14-0314↗
  15. Chemoimmunotherapy targeting Wilms' tumor 1 (WT1)-specific cytotoxic T lymphocyte and helper T cell responses for patients with pancreatic cancer. Co-author DOI 10.4161/21624011.2014.958950↗

Closest collaborators

The 25 strongest of 34 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Shigeo Koido · 12 shared papers, 2014–2019 · strength 0.80
  2. Haruo Sugiyama · 10 shared papers, 2014–2019 · strength 0.71
  3. Shigetaka Shimodaira · 7 shared papers, 2014–2019 · strength 0.46
  4. Zensho Ito · 5 shared papers, 2015–2019 · strength 0.31
  5. Shin Kan · 5 shared papers, 2014–2019 · strength 0.28
  6. Mikio Kajihara · 5 shared papers, 2014–2019 · strength 0.26
  7. Kazuki Takakura · 5 shared papers, 2014–2018 · strength 0.23
  8. Masayuki Saruta · 3 shared papers, 2018–2019 · strength 0.23
  9. Sadamu Homma · 4 shared papers, 2014–2015 · strength 0.16
  10. Sayumi Yoshida · 2 shared papers, 2019 · strength 0.16
  11. Shuichi Fujioka · 2 shared papers, 2018–2019 · strength 0.15
  12. Kazuhiro Nagai · 2 shared papers, 2014–2018 · strength 0.11
  13. Shuichi Hanada · 1 shared paper, 2019 · strength 0.11
  14. Hisao Tajiri · 3 shared papers, 2014–2015 · strength 0.11
  15. Tomoya Kanai · 2 shared papers, 2016–2018 · strength 0.11
  16. Ryu Yanagisawa · 1 shared paper, 2018 · strength 0.08
  17. Toshifumi Ohkusa · 1 shared paper, 2019 · strength 0.08
  18. Sumiyuki Nishida · 1 shared paper, 2018 · strength 0.07
  19. Koichiro Haruki · 1 shared paper, 2016 · strength 0.05
  20. Takeshi Gocho · 1 shared paper, 2016 · strength 0.05
  21. Yuki Fujiwara · 1 shared paper, 2016 · strength 0.05
  22. Koichi Aiura · 1 shared paper, 2015 · strength 0.04
  23. Makoto Sunamura · 1 shared paper, 2015 · strength 0.04
  24. Hiromasa Takaishi · 1 shared paper, 2015 · strength 0.04
  25. Shuhei Mayanagi · 1 shared paper, 2015 · strength 0.04

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.